Vivex Biomedical, Inc. — Form D

Vivex Biomedical, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-26. The offering totals $5.0M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Leo S CookExecutive OfficerAtlanta, GA
Tracy AndersonDirectorLos Angeles, CA
Tracy AndersonExecutive OfficerLos Angeles, CA
John MarshExecutive OfficerHouston, TX
Jeffrey A SmithDirectorCarrollton, GA
Michael RozmajzlExecutive OfficerMilton, GA
TIMOTHY TAYLORDirectorNew York, NY
THOMAS J GIBSONExecutive OfficerATLANTA, GA
Richard E PerlmanDirectorCHICAGO, IL
James K PriceDirectorCHICAGO, IL
Timothy Thomas Ganey, Ph.D.Executive OfficerAtlanta, GA
Holly S MasonExecutive OfficerAtlanta, GA
John A McCallumDirectorAtlanta, GA
Barry Thomas SalzmanDirectorAtlanta, GA
Dr. H Thomas TempleExecutive OfficerAtlanta, GA
Tracy S AndersonDirectorAtlanta, GA
Tracy S AndersonExecutive OfficerAtlanta, GA
J. Miguel Fernandez de CastroDirectorAtlanta, GA
Timothy S TaylorDirectorAtlanta, GA
U. Bertram Ellis, Jr.DirectorAtlanta, GA
Stuart J KomenskiExecutive OfficerAtlanta, GA
Timothy J TaylorDirectorSacramento, CA
Dr. H. Thomas TempleExecutive OfficerMarietta, GA
Barry J SalzmanDirectorMarietta, GA
Ricardo J NunezExecutive OfficerMarietta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2017-05-11D/A$7.0M$6.3M
2016-01-05D$10.0M$6.6M
2013-09-16D/A$7.2M$7.2M
2013-07-18D$5.5M$2.2M

More